Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
10	12	Search

2024	Rational drug repurposing for alzheimer’s treatment using in-silico ligand and structure-based approaches Brazilian Journal of Pharmaceutical Sciences Karishma Rathi, Ravindra Wavhale, Ritesh Bhole, Vaishali Undale, Somdatta Chaudhari
2024	Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer's disease: In silico and in vitro approaches Current Research in Structural Biology Morteza Sadeghi, Seyedehmasoumeh Seyedebrahimi, Mustafa Ghanadian, Mehran Miroliaei
2022	An overview of sulfonamide‐based conjugates: Recent advances for tuberculosis treatment Drug Development Research Cauê Benito Scarim, Fernando Rogério Pavan
2021	Resorcinol derivatives as human acetylcholinesterase inhibitor: An In Vitro and In Silico study International Journal of Chemistry and Technology Uğur Güller
2021	Dual electrophoretically-mediated microanalysis in multiple injection mode for the simultaneous determination of acetylcholinesterase and α-glucosidase activity applied to selected polyphenols Talanta Diogo Alexandre Siebert, Juliana Soares Campos, Michele Debiasi Alberton, Luciano Vitali, Gustavo Amadeu Micke
2020	Synthesis and biological evaluation of 1,2,4-triazolidine-3-thiones as potent acetylcholinesterase inhibitors: in vitro and in silico analysis through kinetics, chemoinformatics and computational approaches Molecular Diversity Prasad G. Mahajan, Nilam C. Dige, Balasaheb D. Vanjare, Hussain Raza, Mubashir Hassan, Sung-Yum Seo, Chong- Hyeak Kim, Ki Hwan Lee
2019	Designing of promising medicinal scaffolds for Alzheimer’s disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches Bioorganic Chemistry Mubashir Hassan, Muhammad Athar Abbasi, Aziz-ur-Rehman, Sabahat Zahra Siddiqui, Saba Shahzadi, Hussain Raza, Ghulam Hussain, Syed Adnan Ali Shah, Muhamamd Ashraf, Muhammad Shahid, Sung-Yum Seo, Arif Malik
2019	The exploration of novel Alzheimer’s therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches Biomedicine & Pharmacotherapy Mubashir Hassan, Hussain Raza, Muhammad Athar Abbasi, Ahmed A. Moustafa, Sung-Yum Seo
2018	Exploration of synthetic multifunctional amides as new therapeutic agents for Alzheimer's disease through enzyme inhibition, chemoinformatic properties, molecular docking and dynamic simulation insights Journal of Theoretical Biology Mubashir Hassan, Muhammad Athar Abbasi, Aziz-ur-Rehman, Sabahat Zahra Siddiqui, Ghulam Hussain, Syed Adnan Ali Shah, Muhammad Shahid, Sung-Yum Seo
	Additional cited-by details will be shown when available from Crossref